Physician
Anderson Regional Medical Center
Anderson Regional Medical Center was paid $4.16M by Medicaid between Jan 2018 and Dec 2024, across 56 billing codes. Its largest line is 64635, — 29% of everything it billed.
33Billing provider infoANDERSON REGIONAL MEDICAL CENTER
MERIDIAN, MS 39301
MERIDIAN, MS 39301
33aNPI1215233986assigned 01/28/2011
33bProvider typeObstetrics & Gynecology Physician
28Total paid$4.16M
24GClaims109,257
24DCodes billed56
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in Mississippi
Rank by total paid#2 of 93
Median peer was paid$93K
This provider vs. median44×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DUCKETT, GREGORY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,059 | $873K | |
| 2019 | 18,985 | $814K | |
| 2020 | 15,409 | $533K | |
| 2021 | 16,022 | $625K | |
| 2022 | 15,619 | $562K | |
| 2023 | 10,987 | $453K | |
| 2024incomplete | 9,176 | $297K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 64635 | 29% | 1,459 | 1,298 | $1.19M | |
| 64493 | 16% | 1,668 | 1,468 | $646K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 14,749 | 13,289 | $546K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 11% | 4,576 | 1,675 | $460K |
| 64483 | 9.1% | 1,301 | 1,208 | $376K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 6.7% | 16,989 | 15,148 | $280K |
| 80305 | 5.3% | 26,295 | 23,198 | $220K | |
| 64490 | 3.4% | 348 | 320 | $140K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 1.3% | 1,428 | 1,257 | $54K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 2,639 | 2,220 | $49K |
| 64633 | <1% | 40 | 40 | $40K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 911 | 769 | $30K |
44 more codes
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 336 | $28K |
| 97597 | <1% | 530 | $27K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 403 | $15K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 97 | $14K |
| 62321 | <1% | 43 | $12K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 529 | $9K |
| 95924 | <1% | 37 | $3K | |
| 11043 | <1% | 24 | $2K | |
| 93923 | <1% | 54 | $2K | |
| 64636 | <1% | 1,564 | $1K | |
| 64491 | <1% | 333 | $966.66 | |
| 82570 | <1% | 612 | $961.06 | |
| 95923 | <1% | 37 | $830.63 | |
| 72110 | <1% | 13 | $784.99 | |
| 87070 | <1% | 168 | $650.68 | |
| 81025 | <1% | 73 | $496.50 | |
| 80061 | Lipid panel | <1% | 37 | $443.45 |
| 87186 | <1% | 60 | $408.74 | |
| 87077 | <1% | 58 | $399.92 | |
| 80053 | Comprehensive metabolic panel | <1% | 39 | $377.80 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 40 | $279.54 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 38 | $273.84 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 16 | $234.96 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 18 | $175.65 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,890 | $167.97 |
| 11045 | <1% | 1,435 | $86.61 | |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | <1% | 4,207 | $32.00 |
| A9270 | Non-covered item or service | <1% | 786 | $20.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,145 | $16.46 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 7,672 | $14.20 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 120 | $10.15 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 134 | $3.93 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 1,534 | $0.00 |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 0% | 96 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 122 | $0.00 |
| 64634 | 0% | 40 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 37 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 12 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 1,413 | $0.00 |
| 64494 | 0% | 1,519 | $0.00 | |
| 64484 | 0% | 1,151 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 231 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 0% | 117 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDUCKETT, GREGORY (SR VP / CLO)
Parent organizationANDERSON REGIONAL MEDICAL CENTER
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.